Wednesday, March 28, 2012 1:44:52 PM
Affymetrix (AFFX) and Lineagen announced that the cos have signed an agreement to incorporate Affymetrix' GeneChip technology into Lineagen's FirstStepDx, a genetic evaluation service for individuals with developmental delay, intellectual disability, and autism spectrum disorders. The FirstStepDx offering is anticipated to be available by mid-2012 and will feature a proprietary microarray-based assay incorporating genetic markers from recently concluded studies of more than 10,000 individuals.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM